Phytonutrient deficiency: The place of palm fruit

Asia Pacific Journal of Clinical Nutrition

Volumn 12, Issue 3, 2003, Pages 363-368

  Wattanapenpaiboon, Naiyana ^a   Wahlqvist, Mark L ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Age related macular degeneration; Antioxidant; Cancer; Cardiovascular disease; Cataracts; Diabetes; Flavonoid; Palm fruit; Phytochemicals; Phytonutrient; Polyphenol

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; ANTIOXIDANT; BETA CAROTENE; CAMPESTEROL; CAROTENOID; FLAVONOID; FREE RADICAL; GAMMA CAROTENE; GLYCOLIPID; OIL; PALM OIL; PHENOL; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; SITOSTEROL; SQUALENE; STEROL; STIGMASTEROL; TOCOPHEROL DERIVATIVE; UNSATURATED FATTY ACID; WATER; EDIBLE OIL; PHENOL DERIVATIVE; PHYTOSTEROL; POLYPHENOLS; VEGETABLE OIL;

AFRICA; ALZHEIMER DISEASE; ANIMAL; ASIA; CARDIOVASCULAR DISEASE; CATARACT; CHEMICAL STRUCTURE; CHRONIC DISEASE; COGNITIVE DEFECT; CONFERENCE PAPER; DIABETES MELLITUS; DIET; EFFLUENT; ELAEIS GUINEENSIS; ENDOSPERM; ENVIRONMENTAL FACTOR; EVALUATION; EXTRACTION; EYE DISEASE; FOOD COMPOSITION; FOOD PROCESSING; FRUIT; HEALTH; HUMAN; LIPID OXIDATION; MALIGNANT NEOPLASTIC DISEASE; NUTRITION; NUTRITIONAL DEFICIENCY; OXIDATION; OXIDATIVE STRESS; PHYTONUTRIENT; PLANT; PLANTATION; POPULATION; PROPHYLAXIS; PROTECTION; RETINA MACULA DEGENERATION; SOLUBILITY; SOUTH AND CENTRAL AMERICA; STRUCTURE ANALYSIS; TROPICS; ARECACEAE; CHEMISTRY; HEALTH FOOD; LIPID METABOLISM; NEOPLASM; NUTRITIONAL VALUE; OXIDATION REDUCTION REACTION; REVIEW;

ANIMALIA; ELAEIS; ELAEIS GUINEENSIS;

AFRICA, WESTERN; ALZHEIMER DISEASE; ARECACEAE; CARDIOVASCULAR DISEASES; CATARACT; CHRONIC DISEASE; COGNITION DISORDERS; DIETARY FATS, UNSATURATED; FLAVONOIDS; FRUIT; HEALTH FOOD; HUMANS; LIPID METABOLISM; MACULAR DEGENERATION; NEOPLASMS; NUTRITIVE VALUE; OXIDATION-REDUCTION; PHENOLS; PHYTOSTEROLS; PLANT OILS;

EID: 2142743810     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (66)

1. Sundram K, Sambanthamurthi R, Tan YA. Palm fruit chemistry and nutrition. Asia Pac J Clin Nutr 2003; 12 (3): 355-362.
2. Sundram K, Sambanthamurthi R, Tan YA. Composition and nutritional characteristics of a water soluble antioxidant rich extract from oil palm processing. 2001 PIPOC International Palm Oil Congress. Food Technology & Nutrition Conference, 20-22 August 2001: 250-3.
3. Shahidi F, Naczk M. Food Phenolics: Sources, Chemistry, Effects, Application. Lancaster: Technomic Publishing, Pennsylvania, 1995.
4. Reische DW, Lillard DA, Eitanmiller RR. Antioxidants. In: Akoh CC, Min Db, eds. Food Lipids - Chemistry, Nutrition and Biotechnology. New York: Marcel Dekker, 1998; 423-48.
5. Kono Y, Shibata H, Kodama Y, Sawa Y. The suppression of the N-nitrosating reaction by chlorogenic acid. Biochem J 1995; 312: 947-53.
6. Kasai H, Fukada S, Yamaizumi Z, Sugie S, Mori H. Action of chlorogenic acid in vegetables and fruits as a inhibitor of 8-hydroxydeoxyguanosine formation in vitro and in a rat carcinogenesis model. Food Chem Toxicol 2000; 38: 467-71.
7. La Vecchia C, Ferraroni M, Negri E, D'Avanzo B, Decarli A, Levi F, Franceschi S. Coffee consumption and digestive tract cancer. Cancer Res 1989; 49: 1049-51.
8. Tavani A, Pregnolato A, La Vecchia C, Negri E, Talamini R, Franceschi S. Coffee and tea intake and risk of cancers of the colon and rectum: a study of 3530 cases and 7057 controls. Int J Cancer 1997; 73: 193-7.
9. Criqui MH, Ringel BL. Does diet or alcohol explain the French paradox? Lancet 1994; 344: 1719-23.
10. Tijburg LBM, Mattern T, Folts JD, Weigeber UM. Katan MB. Tea flavonoids and cardiovascular disease: a review. Crit Rev Food Sci Nutr 1997; 37: 771-85.
11. Ness AR, Powles JW. Fruit and vegetables and cardiovascular disease: a review. Int J Epidemiol 1997; 6: 1-13.
12. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc 1996; 96: 1027-39.
13. Yang CS, Wang ZY. Tea and cancer. J Natl Cancer Inst 1993; 85: 1038-49.
14. Christen WG, Glynn RJ, Hennekens CH. Antioxidants and age-related eye disease. Current and future perspectives. Annals Epidemiol 1996; 6: 60-6.
15. Ortega RM, Requejo AM, Andres P, Lopez-Sobaler AM, Quintas ME, Redondo MR, Navia B, Rivas T. Dietary intake and cognitive function in a group of elderly people. Am J Clin Nutr 1997; 66: 803-9.
16. Middleton E Jr, Kandaswami C. Theoharides TC. The effect of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000; 52: 673-751.
17. Hertog MGL, Feskens EJM, Hollman PCH. Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993; 342: 1007-11.
18. Hertog MGL, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkovic S, Pekkarinen M, Simic B, Toshima H, Feskens EJM, Hollman PCH, Katan MB. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 1995; 155: 381-6.
19. Yochum L, Kushi LH, Meyer K, Folsom AR. Dietary flavonoid intake and risk of cardiovascular disease in post-menopausal women. Am J Epidemiol 1999; 149: 943-9.
20. Keli SO, Hertog MGL, Feskens EJM, Kromhout D. Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch Intern Med 1996; 156: 637-42.
21. Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakulinen T, Aromaa A. Flavonoid intake and risk of chronic disease. Am J Clin Nutr 2002; 76: 560-8.
22. Frankel EN, Kanner J, German JB, Parks E, Kinsela JE. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993; 341: 454-7.
23. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 793-5.
24. Landolfi R, Mower RL, Steiner M. Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Biochem Pharmacol 1984; 33: 1525-30.
25. Negre-Salvayre A, Salvayre R. Quercetin prevents the cytotoxicity of oxidized LDL on lymphoid cell lines. Free Radical Biol Med 1992; 12: 101-6.
26. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witzum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-24.
27. Rotondo S, de Gaetano G. Protection from cardiovascular disease by wine and its derived products. Epidemiological evidence and biological mechanisms. World Rev Nutr Diet 2000; 87: 90-113.
28. Wollin SD, Jones PJH. Alcohol, red wine and cardiovascular disease. J Nutr 2001; 131: 1401-4.
29. Carr A, Frei B. The role of natural antioxidants in preserving the biological activity of endothelium-derived nitric oxide. Free Radical Biol Med 2000; 28: 1806-14.
30. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett W, Peto R. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334: 1145-9.
31. Rapola JM, Virtamo J, Ripatti S, Huttunen JK, Albanes D, Taylor PR, Heinonen OP. Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997; 349: 1715-20.
32. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781-6.
33. Gandini S, Merzenich H, Robertson C, Boyle P. Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients. Eur J Cancer 2000; 36: 636-46.
34. Feskanich D, Ziegler RG, Michaud DS, Giovannucci EL, Speizer FE, Willett WC, Coiditz GA. Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women. J Natl Cancer Inst 2000; 92: 1812-3.
35. Smith-Warner SA, Spiegelman D, Yaun SS, Adami HO, Beeson WL, van den Brandt PA, Folsom AR, Fraser GE. Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA 2001; 14: 769-76.
36. Wu K, Willett WC, Chan JM, Fuchs CS, Colditz GA, Rimm EB, Giovannucci EL. A prospective study on supplemental vitamin E intake and risk of colon cancer in women and men. Cancer Epidemiol Biomarkers Prevention 2002; 11: 1298-304.
37. Hollman PCH, Hertog MGL, Katan MB. Role of dietary flavonoids in protection against cancer and coronary heart disease. Biochem Soc Trans 1996; 24: 785-9.
38. Prieme H, Loft S, Nyyssonen K, Salonen JT, Poulsen HE. No effect of supplementation with vitamin E, ascorbic acid or coenzyme Q on oxidative DNA damage estimated 8-oxo-7,8-dihydro-2′-deoxyguanosine excretion in smokers. Am J Clin Nutr 1997; 65: 503-7.
39. Rehman A, Collis CS, Yang M, Kelly M, Diplock AT, Halliwell B, Rice-Evans C. The effects of iron and vitamin C co-supplementation on oxidative damage to DNA in healthy volunteers. Biochem Biophys Res Commun 1998; 246: 293-8.
40. Rice-Evans CA, Miller NJ. Antioxidant activities of flavonoids as bioactive components of food. Biochem Soc Trans 1996; 24: 790-5.
41. Yang CS, Landau JM, Huang M-T, Newmark HL. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 2001; 83: 2223-35.
42. Hasler CM. Functional foods: their role in disease prevention and health promotion. Food Tech 1998; 52: 63-70.
43. Katiyar SK, Mukhtar H. Tea in chemoprevention of cancer: epidemiologic and experimental studies. Int J Oncol 1996; 8: 221-38.
44. Roy M, Siddiqi M, Bhattacharya RK. Cancer chemoprevention: tea polyphenol induced cellular and molecular responses. Asia Pac J Cancer Prev 2001; 2: 109-16.
45. Weitberg AB, Corvese D. The effect of epigallocatechin gallate and sarcophytol A on DNA strand breakage induced by tobacco-specific nitrosamines and stimulated human phogocytes. J Exp Clin Cancer Res 1999; 18: 433-7.
46. Paschka AG, Butler R, Young CY. Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate. Cancer Lett 1998; 130: 1-7.
47. Otsuka T, Ogo T, Asano Y, Suganuma M, Niho Y. Growth inhibition of leukemic cells by (-)-gallocatechin gallate, the main constituent of green tea. Life Sci 1998; 63: 1397-403.
48. Paolisso G, D'Amore A, Giugliano D, Ceriello A, Varricchio M, D'Onofrio F. Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am J Clin Nutr 1993; 57: 650-6.
49. Tajiri Y, Grill VE. Interactions between vitamin E and glucose on B-cell functions in the rat: an in vivo and in vitro study. Pancreas 1999; 18: 274-81.
50. Packer L, Kraemer K, Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 2001; 17: 888-95.
51. Bhuyan KC, Bhuyan DK. Molecular mechanism of cataractogenesis. III. Toxic metabolites of oxygen as initiators of lipid peroxidation and cataract. Curr Eye Res 1984; 3: 67-81.
52. Jacques PF, Chylack LT Jr. Epidemiologic evidence of a role for the antioxidant vitamins and carotenoids in cataract prevention. Am J Clin Nutr 1991; 53: 352S-5S.
53. Leske MC, Chylack LT, Wu S-Y. The lens opacities case-control study risk factors for cataract. Arch Ophthalmol 1991; 109: 244-51.
54. Jacques PF, Chylack LT Jr, Hankinson SE, Khu PM, Rogers G, Friend J, Tung W, Wolfe JK, Padhye N, Willett WC, Taylor A. Long-term nutrient intake and early age-related nuclear lens opacities. Arch Ophthalmol 2001; 119: 1009-19.
55. Thiagarajan G, Chandani S, Sundari CS, Rao SH, Kulkarni AV, Balasubramanian D. Antioxidant properties of green and black tea, and their potential ability to retard the progression of eye lens cataract. Exp Eye Res 2001; 73: 393-401.
56. Goldberg J, Flowerdew G, Smith E, Brody JA, Tso MOM. Factors associated with age-related macular degeneration: an analysis of data from the First National Health and Nutrition Examination Survey. Am J Epidemiol 1988; 128: 700-10.
57. Eye Disease Case-Control Study Group. Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol 1993; 111: 104-9.
58. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001; 119: 1417-36.
59. Snellen EL, Verbeek AL, Van Den Hoogen GW, Cruysberg JR, Hoyng CB. Neovascular age-related macular degeneration and its relationship to antioxidant intake. Acta Ophthalmol Scand 2002; 80: 368-71.
60. Sackett CS, Schenning S. The age-related eye disease study: the results of the clinical trial. Insight 2002; 27: 5-7.
61. Hyman L, Neborsky R. Risk factors for age-related macular degeneration:an update. Curr Opin Ophthalmol 2002; 13: 171-5.
62. Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JC. Breteler MM. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA. 2002; 287: 3223-9.
63. Luchsinger JA, Tang MX, Shea S, Mayeux R. Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol 2003; 60: 203-8.
64. Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, Lunec J. Vitamin C exhibits pro-oxidant properties [letter] Nature 1998; 392-559.
65. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 1996; 20: 933-56.
66. Ushakova T, Melkonyan H, Nikonova L, Mudrik N, Grogvadze V, Zhukova A, Gaziev AI, Bradbury R. The effect of dietary supplements on gene expression in mice tissues. Free Radical Biol Med 1996; 20: 279-84.